Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-19

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (BluePoint Laboratories Inc.)

View source ↗

Summary

FDA approved an original application for labetalol hydrochloride from BluePoint Laboratories Inc., granting a generic version of the drug market authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)